About M. Thomas Stillman, MD, FACP

At a glance

Gender: Male

Languages: English

Age groups treated: Adult



Commitment to patient-centered care

"I have always stressed the importance of the doctor-patient relationship with emphasis on the bedside examination."

Clinical expertise

Dr. Stillman's major research interests have been arthritis therapy and the use of non-steroidal anti-inflammatory drugs (NSAIDs), renal and gastric toxicity. He has lectured extensively, nationally and internationally on these subjects. He served 7 years on the FDA Arthritis Advisory Committee with particular interest in NSAID related renal issues.

Credentials

Training & education

Medical school
University of Minnesota, Minneapolis, MN, USA

Residency
Internal Medicine, Hennepin Healthcare, Minneapolis, MN, USA

Fellowships
Clinical Rheumatology, Mayo Clinic, Rochester, MN, USA
Rheumatology, Madigan General Hospital, Tacoma, WA, USA

Awards and honors

AOA Faculty Teaching Award 2016

Selected by U of MN students to be "greeter" for past 16 commencement ceremonies

Minnesota Medical Foundation Distinguished Teaching Award/Clinical Faculty, 1996-2000, 2004

Minnesota Medical Foundation Outstanding Medical School Teacher Award, 1998

Lifetime Teaching Award from the Minnesota Medical Foundation, 2005

Harold S. Diehl Award, 2005

Leonard Tow Humanism in Medicine Award, 2008

University of Minnesota Cardiology Fellows' Faculty Teaching Award, 2009

My experiences & interests

Publications
  • Stillman MJ, Stillman MT. Appropriate use of NSAIDs; Considering cadiovascular risk in the elderly. Geriatrics. 2007;62(3):16-21.
  • Stillman MJ, Stillman MT. Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly; a clinical use pathway. Geriatrics. 2007;62(2):26-34.
  • Stillman MT, Schlesinger PA. NSAID nephrotoxicity: should we be concerned? Arch Intern Med. 1990;150:268-270.
  • Blackshear JL, Napier JS, Davidman M, Stillman MT. Renal complications of non-steroidal anti-inflammatory drugs: identification and monitoring of those at risk. Semin Arthritis Rheum.1985;14:163-175.
  • Stillman MT, Napier JS. Adverse effects of non-steroidal anti-inflammatory drugs on the kidney. Med Clin North Am.1984;68:371-385.
Professional affiliations
  • Alpha Omega Alpha Honor Medical Society
  • American Rheumatism Association
  • CDIM Clerkship Directors in Internal Medicine
  • Fellow, American College of Physicians
  • Founding Fellow, American College of Rheumatology
  • Gold Humanism Honor Society
  • Hennepin County Medical Society
  • Minneapolis Society of Internal Medicine
  • Minnesota Arthritis Foundation
  • Minnesota Medical Directors Association
  • Phi Beta Kappa
Licenses and accreditations
  • Director of the Division of Rheumatology, HCMC for 30 years
  • Director of Undergraduate Medical Education for 17 years
  • Professor of Medicine, University of Minnesota School of Medicine